Category: Pharma & drug development
Understanding drug-resistant TB
How do cancer cells communicate and can it help us catch them?
Proteomics and the promise of ‘enriching’ clinical trials
Is growth factor protein the future of Parkinson’s treatment?
The drugs fighting memory loss
Medical cannabis in the UK: how has the roll out gone so far?
Thumbs up for esketamine
Access to antivenom needs attention
Developing a new class of cancer combo drugs
Is a lack of female participants skewing heart disease trial results?
Using AI to personalise drug combination therapy
Manufacturing personalised meds: what needs to change?
Gene and cell therapies: making manufacturing work
Disposable diagnostics
Philanthropy in pharma: a look inside the ISPE Foundation
The next generation of antimalarials
Could cutting out mediators let cancer research off the leash?
Cannabinoids breakthrough signals hope for epilepsy treatment
Journalist portfolio 